It seems likely that short-term gains are made at the expense of increasing problems such as antibiotic resistance. The only alternatives are to ensure practitioners have the skills to appraise medicine promotion activities or to more stringently control pharmaceutical promotional activities.
It appears probable that short-term benefits are achieved at the cost of escalating issues such as antibiotic resistance. The only options are to guarantee practitioners possess the expertise to evaluate medicine promotion activities or to more rigorously regulate pharmaceutical promotional activities.